| |
| |
|
| Insider
Information: |
Steiner Mitchell Shuster |
| Relationship: |
President and CEO, Dir... |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
9,072,631 |
|
|
Indirect Shares
|
2,687,445 |
|
|
| Direct
Value |
$7,741,847 |
|
|
|
Indirect Value
|
$1,016,824 |
|
|
| Total
Shares |
11,760,076 |
|
|
| Total
Value |
$8,758,672 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-8.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -230.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
Chief Executive Office... |
2012-07-16 |
2,129,922 |
2012-07-16 |
2,543,445 |
Premium* |
|
|
Veru Inc |
VERU |
President and CEO, Dir... |
2024-05-24 |
6,942,709 |
2024-05-24 |
144,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-06 |
4 |
AS |
$11.41 |
$71,670 |
I/I |
(6,189) |
437,811 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-07 |
4 |
AS |
$10.85 |
$27,666 |
I/I |
(2,496) |
430,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-07 |
4 |
AS |
$10.84 |
$49,508 |
I/I |
(4,504) |
432,496 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-12 |
4 |
AS |
$10.81 |
$75,933 |
I/I |
(7,000) |
423,000 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-13 |
4 |
AS |
$10.83 |
$47,713 |
I/I |
(4,390) |
416,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-13 |
4 |
AS |
$10.82 |
$28,464 |
I/I |
(2,610) |
420,390 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-18 |
4 |
AS |
$10.52 |
$74,007 |
I/I |
(7,000) |
409,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-19 |
4 |
AS |
$10.46 |
$63,523 |
I/I |
(6,032) |
402,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-19 |
4 |
AS |
$10.55 |
$10,212 |
I/I |
(968) |
408,032 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-26 |
4 |
AS |
$10.04 |
$61,528 |
I/I |
(6,093) |
395,907 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-26 |
4 |
AS |
$10.10 |
$9,187 |
I/I |
(907) |
395,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-27 |
4 |
AS |
$9.82 |
$26,447 |
I/I |
(2,666) |
388,000 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-27 |
4 |
AS |
$9.78 |
$38,025 |
I/I |
(3,834) |
390,666 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-27 |
4 |
AS |
$9.91 |
$4,955 |
I/I |
(500) |
390,766 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-05-04 |
4 |
AS |
$10.08 |
$70,575 |
I/I |
(7,000) |
381,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-05-05 |
4 |
AS |
$9.87 |
$69,108 |
I/I |
(7,000) |
374,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-05-10 |
4 |
AS |
$9.34 |
$65,379 |
I/I |
(7,000) |
367,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-05-11 |
4 |
AS |
$9.05 |
$63,361 |
I/I |
(7,000) |
360,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-05-17 |
4 |
AS |
$8.76 |
$61,296 |
I/I |
(7,000) |
35,300 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-05-18 |
4 |
AS |
$8.71 |
$60,955 |
I/I |
(7,000) |
346,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-05-22 |
4 |
AS |
$8.37 |
$58,589 |
I/I |
(7,000) |
339,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-05-23 |
4 |
AS |
$8.27 |
$57,863 |
I/I |
(7,000) |
332,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-06-01 |
4 |
AS |
$8.62 |
$60,361 |
I/I |
(7,000) |
325,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-06-02 |
4 |
AS |
$8.94 |
$62,563 |
I/I |
(7,000) |
318,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-06-07 |
4 |
AS |
$8.60 |
$60,224 |
I/I |
(7,000) |
311,000 |
|
- |
|
148 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
